From Diagnosis to Surgery: How AI Tech Is Quietly Reshaping Healthcare Profits
USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – The AI revolution in healthcare is fully underway, with the potential to save lives and money, but there’s still more to come. Healthcare startups...
Avant Technologies’ Joint Venture Partner Presents AI Technology at Roche Ophthalmology Conference
LAS VEGAS, NEVADA, July 22, 2025 - Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging technology company developing healthcare solutions using both artificial intelligence (AI) and developments in biotechnology, today announced that Vinicio...
Oncolytics Biotech® to Host Key Opinion Leader Discussion Focusing on Pancreatic and Gastrointestinal Cancers
KOL webinar to take place on July 22, 2025, at 1:00 p.m. ET SAN DIEGO, CA and CALGARY, AB, July 10, 2025 – Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, announced that it will host a...
Scope Technologies Expands Product Leadership with Appointment of Andrew Knight as Vice President of Product
VANCOUVER, BC, July 10, 2025 — Scope Technologies Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) ("Scope Technologies" or the "Company") is pleased to announce the appointment of Andrew Knight as Vice President of Product. Mr. Knight brings nearly two decades of...
BIOVAXYS ENGAGES ENCLAVE CAPITAL LLC TO ACT AS AN AGENT IN BROKERED PRIVATE PLACEMENT OFFERING
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, July 7, 2025 – BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or the “Company”) announces it has engaged Enclave Capital LLC...
Avant Technologies Creating New Company for Expansion of Diabetes Program
LAS VEGAS, NEVADA, June 24, 2025 - Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging technology company developing healthcare solutions using both artificial intelligence (AI) and developments in biotechnology, today announced that it will...
Avant Technologies’ JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies
LAS VEGAS, NEVADA, June 17, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial...
Avant Technologies Signs Letter of Intent for a Business Combination
LAS VEGAS, NEVADA, June 10, 2025 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), today announced that it has entered into a non-binding letter of intent (“LOI”) for a potential business combination with Ainnova Tech, Inc. (Ainnova). Ainnova, the...
Scope Technologies Announces Leadership Transition: Ted Carefoot Appointed CEO
Vancouver, British Columbia, June 5, 2025 – Scope Technologies Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) (“Scope Technologies” or the “Company”) today announced the appointment of Ted Carefoot as Chief Executive Officer, succeeding James Young, who will continue...
BioVaxys Issues Corporate Update
VANCOUVER, BC, June 3rd, 2025 -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of current operating initiatives including the integration and disposition of assets acquired in February 2024 from the...
Exchange News
Regulatory News
Media Relations
Public Relations
Disclosure Services